Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP85VVHFFKNIVTP96RT in multiple sclerosis patients

Multiple Sclerosis

Volumn 6, Issue 5, 2000, Pages 300-311

  Warren, K G ^a   Catz, Ingrid ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anti MBP; Autoimmunity; Multiple sclerosis; Synthetic peptides; Tolerance

Indexed keywords

DEN85VVHFFKNIVTP96RT; MYELIN BASIC PROTEIN; PROTEIN ANTIBODY; PROTEIN P85; SPMBP82 98; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CEREBROSPINAL FLUID LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; HUMAN; INHIBITION KINETICS; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; PHASE 1 CLINICAL TRIAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; AUTOANTIBODIES; COHORT STUDIES; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; INJECTIONS, INTRAVENOUS; KINETICS; MALE; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS;

EID: 0033754799     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245850000600502     Document Type: Article

References (67)

1. Etude anatomique et clinique sur la sclerose en plaques pour Le doctorat en Medecine presente et soutenu le 9 Mars, Paris
2. Candidate autoantigens in multiple sclerosis
3. Adoptive transfer of myelin basic protein-specific T cells produces chronic relapsing demyelinating disease in mice
4. Experimental allergic encephalomyelitis mediated by murine encephalitogenic T cell lines specific for myelin proteolipid apoprotein
5. The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein
6. Creation of a model for multiple sclerosis in Callithrix jacchus marmosets
7. Isolation of myelin basic protein reactive T cells from normal human blood
8. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals
9. T and B cell responses to myelinoligodendrocyte glycoprotein in multiple sclerosis
10. Diversity of T cell receptor α and β chain genes expressed by human T cells, specific for similar myelin basic protein major histocompatibility complexes
11. Reactivity to myelin antigens in multiple sclerosis: Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein
12. + T cells from MS patients
13. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans
14. A myelin basic protein specific T cell line that mediates experimental allergic encephalomyelitis
15. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ
16. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis
17. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones
18. Increased frequency of interleukin-2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
19. TCR usage in human and experimental demyelinating disease
20. Immunological and inflammatory disorders of the central nervous system
21. T cell responses to myelin antigens in multiple sclerosis: Relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein
22. Autoantibodies to MBP within MS CNS tissue
23. Human cytotoxic T cell recognition of a synthetic peptide of myelin basic protein
24. Myelin autoreactivity in multiple sclerosis: Recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of MS patients and healthy donors
25. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis
26. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity and cytotoxicity
27. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients
28. The T-cell response to myelin basic protein in familial multiple sclerosis: Diversity of fine specificity, restricting elements, and T-cell receptor usage
29. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones
30. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for myelin basic protein in brain lesions of multiple sclerosis
31. Clonal expansion and peristence of human T cells specific for an immunodominant myelin basic protein peptide
32. Human T-cell response to myelin basic protein (83-99). Extensive heterogeneity in antigen recognition, function, and phenocyte
33. Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein
34. CSF antibody to myelin basic protein: Measurements in patients with multiple sclerosis and subacute sclerosing panencephalitis
35. Antibody to myelin basic protein in extracts of multiple sclerosis brain
36. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients
37. Diagnostic value of cerebrospinal fluid anti-myelin basic protein in patients with multiple sclerosis
38. Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis
39. A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients
40. Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid
41. Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: The minimal B cell epitope and a model of its features
42. 2-restricted T cell clones from multiple sclerosis patients: Identity of key contact residues in the B cell and T cell epitopes
43. Long-term development of the human MBP specific T cell repertoire: Epitope spreading versus clonal persistence
44. An extensive search for autoantibodies to myelin basic protein in CSFR of nonMS patients: Implications for the pathogenesis of MS
45. A unique population of circulating autoantibodies promotes central nervous system demyelination
46. A monoclonal antibody against at myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease
47. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate
48. Late complications of immune deviation therapy in a nonhuman primate
49. Administration of myelin basic protein synthetic peptide to multiple sclerosis patients
50. 96 on free anti-MBP levels in acute relapsing multiple sclerosis
51. 96 in chronic progressive multiple sclerosis
52. Identification of autoantibodies associated with myelin damage in multiple sclerosis
53. Demyelination in primary autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation
54. Immunologic tolerance
55. Problems of experimental trials of therapy in MS. Report by the panel on evaluation of experimental trials in MS
56. New diagnostic criteria for multiple sclerosis
57. Anti-MBP and anti-PLP specific forms of MS
58. Large scale preparation of myelin basic protein from central nervous system tissue of several mammalian species
59. Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis
60. T cells responsive to myelin basic protein in patients with multiple sclerosis
61. Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebrospinal fluid IgG of multiple sclerosis patients. Immunoreactivity studies with human myelin basic protein
62. + T cells
63. Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor
64. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
65. How the immune system learns about self
66. Isolation of myelin basic protein-specific T-cells predominantly from the memory T-cell compartment in multiple sclerosis
67. A new look at MHC and autoimmune disease